We thank Federica Genovesi-Ebert, PhD, Tomaso Caporossi, MD, Francesco Barca, MD, and Emanuele di Bartolo, PhD for their contributions as investigators and as critical reviewers of the study proposal.
Ethical standards
Following a detailed explanation of the risks and benefits of receiving the Argus II Retinal Prosthesis System, written informed consent was obtained from the patient. The information presented here came from a larger study, which was approved by the Azienda Ospedaliero-Universitaria Pisana Ethics Committee in March 2012. This larger study is registered at ClinicalTrials.gov (identifier NCT01490827). Study conduct adhered to the tenets of the Declaration of Helsinki and its later amendments.
Conflicts of interest
The authors have no conflicts of interest to declare.